TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
APGE

Apogee Therapeutics, Inc.

Healthcare · Biotechnology

135.10$ +0.0% vs. previous close Closing price · As of: Sep 3, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow APGE
Line item 2022 2023 2024 2025
– – – –
– – – +650.3%
– +184.9% +282.3% +98.3%
– -37.8% -132.8% –
– – +589.8% +346.8%
– – +9.7% -40.2%
– +87.4% +57.0% -19.9%
– -121.9% – -144.9%
– – – –

Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?